glp-1 news november 2025 today in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity 2025 dominates for GLP-1 trial

Smatra se jednim od najistraivanijih peptida kada je rije o modelima povezanim s miino-kotanim sustavom, krvnim ilama i probavnim traktom

Integration used CCA on the top 3,000 variable genes, followed by PCA and clustering (resolution = 1, top 30 PCs)

had previous corneal surgery

Why it matters: Up to 85% of people who develop type 1 diabetes do not have a family history of it, which is why preventing new-onset cases of DKA will require more general screening efforts

Understanding both approved and research applications helps frame realistic expectations

Thompson is widely recognized for his gentle, low-discomfort injection techniques